Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now indicates no longer looking for participants. New navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the Intervention/Treatment header formatting was adjusted, and the page revision was updated to v3.6.0.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page’s revision number was updated from v3.5.4 to v3.5.5, indicating a minor update to the record’s metadata.SummaryDifference0.0%

- Check41 days agoChange DetectedPublications entries were updated. The Sharma et al. CheckMate 032 Lancet Oncology paper was added with its citation, and the prior erratum reference was replaced with a revised entry (version 3.5.4).SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now displays a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a software update to the page.SummaryDifference0.0%

- Check70 days agoChange DetectedAdded a publication citation for Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032) from Lancet Oncology with an Erratum. Replaced the older citation version (v3.5.0) with the updated entry (v3.5.2).SummaryDifference0.1%

- Check77 days agoChange DetectedPadua, Italy, 35128 was deleted and Padova, Italy, 35128 was added in the Locations section.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.